<DOC>
	<DOC>NCT01016782</DOC>
	<brief_summary>The aim of this trial is to assess the efficacy of Metronidazole Topical Gel 1% in the Treatment of Inflammatory Lesions of Rosacea. Treatment medication will be administered as follows: A thin film of gel will be applied and rubbed into the entire face once daily for a period of 70 days.</brief_summary>
	<brief_title>Study of 0444 Gel in the Treatment of Inflammatory Lesions of Rosacea</brief_title>
	<detailed_description />
	<mesh_term>Rosacea</mesh_term>
	<criteria>Clinical diagnosis of rosacea Good health with the exception of rosacea Papsules and pustules minimum and maximum requirements Subjects who are pregnant, nursing, or planning a pregnancy within the study participation period. Subjects who have any systemic or dermatological disorders with the exception of rosacea</criteria>
	<gender>All</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>N/A</maximum_age>
	<verification_date>July 2014</verification_date>
	<keyword>Inflammatory Rosacea</keyword>
	<keyword>Rosacea</keyword>
</DOC>